Packing polymorphism of a conformationally flexible molecule (aprepitant)

被引:54
作者
Braun, Doris E. [1 ]
Gelbrich, Thomas [1 ]
Kahlenberg, Volker [2 ]
Laus, Gerhard [3 ]
Wieser, Josef [4 ]
Griesser, Ulrich J. [1 ]
机构
[1] Univ Innsbruck, Inst Pharm, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Inst Mineral & Petrog, A-6020 Innsbruck, Austria
[3] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Austria
[4] Sandoz GmbH, A-6250 Kundl, Austria
关键词
D O I
10.1039/b805438j
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This work highlights the structural and thermochemical differences of two modi. cations of the NK1 receptor antagonist aprepitant. Form I degrees is the stable polymorph and crystallises in the orthorhombic space group P2(1)2(1)2(1) whereas the metastable form II is monoclinic ( space group P2(1)). The monotropically related polymorphs show only minor differences in melting point and heat of fusion (T-fus,T-I = 253.6, Delta H-fus(I) = 53.7 kJ mol(-1), T-fus,T-II = 253.0 degrees C, Delta H-fus(II) = 52.4 kJ mol(-1)) and often crystallise concomitantly. The forms exhibit a very close structural relationship based on a common 2D packing fragment, which is in fact a stack of 1D N-H center dot center dot center dot O hydrogen bonded ribbon chains. Forms I degrees and II may therefore be interpreted as two distinct stacking modes of this common 2D unit. The alternative modes are associated with slight differences in weaker intermolecular interactions. Somewhat surprisingly, the aprepitant molecule adopts almost the same conformation in the two crystal structures in spite of its potential conformational flexibility. Hirshfeld surface analysis was successfully deployed to visualise and elaborate the small differences in the molecular environments of the two polymorphs. The study emphasises the benefit of single-crystal structure data for the judgement of the phase purity and of polymorphs exhibiting only weak energetical and structural differences.
引用
收藏
页码:1677 / 1685
页数:9
相关论文
共 57 条
[11]   On the polymorphism of aspirin [J].
Bond, Andrew D. ;
Boese, Roland ;
Desiraju, Gautam R. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2007, 46 (04) :615-617
[12]   Understanding the origin of unusual stepwise hydrogenation kinetics in the synthesis of the 3-(4-fluorophenyl)morpholine moiety of NK1 receptor antagonist aprepitant [J].
Brands, KMJ ;
Krska, SW ;
Rosner, T ;
Conrad, KM ;
Corley, EG ;
Kaba, M ;
Larsen, RD ;
Reamer, RA ;
Sun, YK ;
Tsay, FR .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2006, 10 (01) :109-117
[13]   Efficient synthesis of NK1 receptor antagonist aprepitant using a crystallization-induced diastereoselective transformation [J].
Brands, KMJ ;
Payack, JF ;
Rosen, JD ;
Nelson, TD ;
Candelario, A ;
Huffman, MA ;
Zhao, MM ;
Li, J ;
Craig, B ;
Song, ZGJ ;
Tschaen, DM ;
Hansen, K ;
Devine, PN ;
Pye, PJ ;
Rossen, K ;
Dormer, PG ;
Reamer, RA ;
Welch, CJ ;
Mathre, DJ ;
Tsou, NN ;
McNamara, JM ;
Reider, PJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (08) :2129-2135
[14]  
Brittain HG, 1999, DRUGS PHARM SCI, V95, P279
[15]  
BURGER A, 1979, MIKROCHIM ACTA, V2, P273
[16]   POLYMORPHISM OF PHARMACEUTICALS AND OTHER MOLECULAR-CRYSTALS .1. THEORY OF THERMODYNAMIC RULES [J].
BURGER, A ;
RAMBERGER, R .
MIKROCHIMICA ACTA, 1979, 2 (3-4) :259-271
[17]   Reactivity differences of indomethacin solid forms with ammonia gas [J].
Chen, XM ;
Morris, KR ;
Griesser, UJ ;
Byrn, SR ;
Stowell, JG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (50) :15012-15019
[18]   Study of lactol activation by trifluoroacetic anhydride via in situ Fourier transform infrared spectroscopy [J].
Chen, YD ;
Zhou, GX ;
Brown, N ;
Wang, T ;
Ge, ZH .
ANALYTICA CHIMICA ACTA, 2003, 497 (1-2) :155-164
[19]   A new synthesis of 1,2,4-triazolin-5-ones:: application to the convergent synthesis of an NK1 antagonist [J].
Cowden, CJ ;
Wilson, RD ;
Bishop, BC ;
Cottrell, IF ;
Davies, AJ ;
Dolling, UH .
TETRAHEDRON LETTERS, 2000, 41 (44) :8661-8664
[20]   Aprepitant - A review of its use in the prevention of chemotherapy-induced nausea and vomiting [J].
Dando, TM ;
Perry, CM .
DRUGS, 2004, 64 (07) :777-794